Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal stem cell conditioned medium for autonomic nervous system-related disorders
jRCT1051260048Recruiting
- Sponsor
- Stem Cell Clinic Tokyo
- Start
- Mar 2026
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label, single-arm trial of human-derived mesenchymal stem cell conditioned medium in dysautonomia, sponsored by Stem Cell Clinic Tokyo. Primary endpoint: Self-aware symptoms of autonomic nervous system dysfunction. Started Mar 2026; status: recruiting.
02
Drugs
human-derived mesenchymal stem cell conditioned medium
03
Conditions
dysautonomia
Beyond the preview
Go deeper on jRCT1051260048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051260048.